For patients with relapsed BRCA-mutated ovarian carcinoma, rucaparib produced a median OS of 19.4 months vs 25.4 months with chemotherapy in new findings.

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, and safety of rasagiline are reviewed. Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and ...

This morning, at 7 AM, the civilian ship Sea Eye 4 arrived in Naples with 41 migrants on board (including some minors) coming ...

I sometimes have a strange feeling of spinning movement around me. A friend of mine in the health sector believed that I am suffering from Vertigo. Kindly let me know what this is all about.

Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...

Radiographic progression-free survival (rPFS) in metastatic castration-resistant prostate cancer (mCRPC) more than doubled with the addition of an investigational targeted therapy to standard ...

Last year’s Pune Half Marathon race title winner Pradhan Vilas Kirulakar has been provisionally suspended by the Athletics Integrity Unit (AIU) after failing a dope test. Kirulakar, who had won the ...

During a Case-Based Roundtable® event, Evan J. Lipson, MD, moderated a discussion on the tolerability of immunotherapy in ...

The FDA granted breakthrough therapy status to first-line petosemtamab plus pembrolizumab for PD-L1–positive recurrent or ...

Polk County Schools are shifting to virtual learning while the district deals with a spike in flu and norovirus cases. The county says that more than 10% of the student population at each of its ...

Patients with advanced urothelial carcinoma had prolonged survival with Bavencio and BSC treatment, regardless of diabetes ...

CNW/ - Pharmascience Canada is proud to announce the launch of  Pr  pms-RUPATADINE (rupatadine), a treatment that helps relieve nasal and non-nasal ...